Lifestance Health Group (LFST) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
Annual meeting scheduled for June 2, 2026, to be held virtually for stockholders of record as of April 10, 2026.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request by May 22, 2026.
Voting matters and shareholder proposals
Election of two director nominees, David Bourdon and Robert Bessler, M.D., to serve until the 2029 Annual Meeting.
Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026.
Advisory approval of named executive officer compensation (say-on-pay).
Other business may be transacted as properly brought before the meeting.
Board of directors and corporate governance
Board recommends a vote FOR all three main proposals on the agenda.
Latest events from Lifestance Health Group
- Q2 2026 revenue up 26% to $435.4M, net income $23.6M, guidance and share buybacks increased.LFST
Q2 2026 - National mental health leader posts strong growth, raises 2026 outlook, and expands margins.LFST
Investor presentation - Hybrid care, rapid growth, and focus on quality outcomes drive industry leadership.LFST
46th Annual William Blair Growth Stock Conference - Hybrid mental health provider targets mid-teens EBITDA margins by 2028 amid strong industry growth.LFST
Bank of America Global Healthcare Conference 2026 - Revenue up 21% to $403.5M, net income $14.2M, and 2026 guidance raised on strong growth.LFST
Q1 2026 - Shareholders will vote virtually on directors, auditor ratification, and executive pay amid strong results.LFST
Proxy filing - Record revenue and earnings growth, margin expansion, and $100M share repurchase announced.LFST
Q4 2025 - Q2 revenue up 20%, Adjusted EBITDA doubled, and guidance raised for 2024.LFST
Q2 2024 - Margin expansion and strategic M&A set to drive growth beyond 2025, despite near-term payer headwinds.LFST
Goldman Sachs 45th Annual Global Healthcare Conference